SABR for Medically Inoperable Early Stage NSCLC at the Beatson West of Scotland Cancer Centre: Outcomes and Toxicity

被引：0
|
作者：
McKay, Stephen [1 ]
Moore, Karen [1 ]
MacPhee, Jennifer [1 ]
Hicks, Jonathan [1 ]
Lumsden, Graeme [1 ]
Maclaren, Vivienne
Aitken, Andy [2 ]
Stobo, David [3 ]
Cowell, Gordon [3 ]
Mcloone, Philip [4 ]
Harrow, Stephen [1 ]
机构：
[1] Beatson West Scotland Canc Ctr, Glasgow, Lanark, Scotland
[2] Beatson West Scotland Canc Ctr, Radiotherapy Phys Sect, Dept Clin Phys & Bioengn, Glasgow, Lanark, Scotland
[3] Victoria Infirm, Clin Radiol, Glasgow, Lanark, Scotland
[4] Univ Glasgow, Inst Hlth & Wellbeing, Glasgow, Lanark, Scotland
来源：
JOURNAL OF THORACIC ONCOLOGY | 2017年 / 12卷 / 01期
关键词：
SABR; NSCLC;
D O I：
10.1016/j.jtho.2016.11.819
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P1.05-035
引用
收藏
页码：S635 / S636
页数：2
相关论文
共 50 条
  • [1] BEATSON WEST OF SCOTLAND CANCER CENTRE EXPERIENCE OF NEOADJUVANT CHEMOTHERAPY FOR INITIALLY INOPERABLE ENDOMETRIAL CANCER.
    Harrand, R.
    Sadozye, A.
    Siddiqui, N.
    Burton, K.
    Shanbhag, S.
    Davis, J.
    Alexander-Sefre, F.
    Reed, N. S.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2013, 23 (08)
  • [2] Clinical outcomes of stereotactic ablative body radiotherapy (SABR) in medically inoperable early stage lung cancer patients
    Groves, Jonathan
    Yeo, Ryan
    Tsang, Yat
    Shah, Nihal
    Win, Thida
    EUROPEAN RESPIRATORY JOURNAL, 2021, 58
  • [3] Stereotactic Ablative Radiotherapy (SABR) in Patients with Medically Inoperable Peripheral Early Stage Lung Cancer: Outcomes for the First UK SABR Cohort
    Murray, L.
    Ramasamy, S.
    Lilley, J.
    Snee, M.
    Clarke, K.
    Musunuru, H. B.
    Needham, A.
    Turner, R.
    Sangha, V.
    Flatley, M.
    Franks, K.
    CLINICAL ONCOLOGY, 2016, 28 (01) : 4 - 12
  • [4] Stereotactic ablative radiotherapy (SABR) in medically inoperable early stage non-small cell lung cancer (NSCLC): A single tertiary UK centre experience
    Yip, C.
    Landau, D. B.
    Thomas, C.
    Ahmad, S.
    LUNG CANCER, 2013, 79 : S58 - S58
  • [5] Role and outcomes of high dose palliative thoracic radiotherapy at the Beatson West of Scotland Cancer Centre
    Campbell, K.
    McKay, S.
    Featherstone, C.
    LUNG CANCER, 2017, 103 : S60 - S60
  • [6] Stereotactic ablative radiotherapy (SABR) for early stage, medically inoperable non-small cell lung cancer (NSCLC): clinical outcome of 5 years of experience at the Oxford Cancer Centre
    Pascal, L.
    Bull, L.
    Ajzensztejn, D.
    Higgins, G.
    Stuart, R.
    Panakis, N.
    LUNG CANCER, 2018, 115 : S61 - S61
  • [7] Stereotactic ablative radiotherapy for early stage, medically inoperable NSCLC - outcomes from a single non-academic centre in the UK
    Veeratterapillay, J.
    Aynsley, E.
    Kumar, G.
    Masinghe, S.
    Green, J.
    Daniel, J.
    Burke, K.
    Greenhalgh, A.
    Reynolds, J.
    Huntley, C.
    Bradley, J.
    Peedell, C.
    LUNG CANCER, 2018, 115 : S61 - S61
  • [8] Lung SABR for Early Stage Lung Cancer: Outcomes and Toxicity of 803 Patients Treated at the Leeds Cancer Centre
    Murray, Patrick
    Clarke, Katy
    Franks, Kevin
    Dickinson, Peter
    Lilley, John
    Snee, Michael
    Jain, Pooja
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (01) : S632 - S632
  • [9] XELOX -TREATMENT-RELATED TOXICITY INPATIENTS WITH COLORECTAL CANCER (CRC): THE BEATSON WEST OF SCOTLAND CANCER CENTRE EXPERIENCE
    Samol, J.
    Waterston, A.
    Hennessy, A.
    Cassidy, J.
    ANNALS OF ONCOLOGY, 2009, 20 : 73 - 74
  • [10] Implementation of stereotactic ablative body radiotherapy (SABR) for early stage medically inoperable lung cancer: an experience from a medium size clinical centre
    Tambe, N. S.
    Colley, W. R.
    Marsden, J. E.
    Beavis, A. W.
    Wieczorek, A.
    El-Mandawi, N.
    LUNG CANCER, 2015, 87 : S48 - S48
12345